Chemoinformaics analysis of 4-methyl-2-[(1z)-3-methylbuta-1,3-dienyl]oxolane
Molecular Weight | 152.237 | nRot | 2 |
Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
Exact Molecular Weight | 152.12 | nRing | 1 |
Solubility: LogS | -2.55 | nHRing | 1 |
Solubility: LogP | 2.703 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 0 | BPOL | 17.7873 |
QED | 0.552 |
Synth | 4.287 |
Natural Product Likeliness | 2.594 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.008 |
CACO-2 | -4.479 |
MDCK | 0.0000369 |
BBB | 0.925 |
PPB | 0.666824 |
VDSS | 1.474 |
FU | 0.246643 |
CYP1A2-inh | 0.133 |
CYP1A2-sub | 0.332 |
CYP2c19-inh | 0.05 |
CYP2c19-sub | 0.893 |
CYP2c9-inh | 0.029 |
CYP2c9-sub | 0.191 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.689 |
CYP3a4-inh | 0.026 |
CYP3a4-sub | 0.378 |
CL | 11.91 |
T12 | 0.579 |
hERG | 0.033 |
Ames | 0.855 |
ROA | 0.095 |
SkinSen | 0.959 |
Carcinogencity | 0.745 |
EI | 0.98 |
Respiratory | 0.939 |
NR-Aromatase | 0.017 |
Antiviral | No |
Prediction | 0.918663 |